Saturday 17 October 2026
Export COR’s income statement to Excel — free account
Cencora, Inc.
COR Healthcare Medical Distribution
Cencora, Inc.’s revenue for fiscal 2025 (year ended September 2025) was $321.3 billion, up 9.31% from fiscal 2024. In the quarter to June 2026, revenue grew 5.07%, EPS grew 11.3%, free cash flow grew 3,385.3% and total debt rose 42.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for three consecutive years, revenue growth for ten; insiders bought in the last twelve months.
340.66
0.75
−0.22%
Follow COR
| Sep '25 | Sep '24 | Sep '23 | Sep '22 | Sep '21 | Sep '20 | Sep '19 | Sep '18 | Sep '17 | Sep '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
38.97 | 29.69 | 20.80 | 16.63 | 15.97 | 0.00 | 20.23 | 12.21 | 43.84 | 11.90 |
Piotroski F-Score |
6 | 7 | 6 | 5 | 5 | 5 | 8 | 6 | 6 | — |
Altman Z-Score |
4.83 | 4.89 | 4.65 | 4.65 | 4.11 | 4.17 | 5.07 | 5.01 | 4.77 | 4.85 |
P/S ratio |
0.19 | 0.15 | 0.14 | 0.12 | 0.11 | 0.10 | 0.10 | 0.12 | 0.12 | 0.12 |
Altman Z″-Score (non-manufacturers) |
0.06 | (0.15) | (0.14) | 0.00 | 0.09 | (0.88) | 0.39 | 0.33 | 0.02 | 0.13 |
P/FCF ratio |
18.89 | 14.91 | 10.50 | 12.78 | 11.04 | 10.59 | 8.50 | 18.67 | 17.53 | 6.32 |
P/Operating CF |
19.33 | 44.66 | 19.85 | 24.23 | 24.36 | 15.28 | 25.72 | 30.38 | 13.18 | 12.66 |
Beneish M-Score |
(2.54) | (2.53) | (2.51) | (2.67) | (2.10) | (3.32) | (2.64) | (2.30) | (2.61) | (2.61) |
Dividend Safety Score |
74 | — | — | — | — | — | — | — | — | — |
P/B ratio |
34.67 | 56.79 | 54.43 | 395.84 | 42.09 | 0.00 | 5.78 | 6.63 | 8.81 | 8.05 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
0.20 | 0.16 | 0.15 | 0.13 | 0.13 | 0.10 | 0.10 | 0.13 | 0.13 | 0.13 |
EV/EBITDA |
17.28 | 13.94 | 11.58 | 9.92 | 9.91 | 0.00 | 11.45 | 11.12 | 13.10 | 9.83 |
EV/Operating CF |
16.48 | 13.18 | 9.83 | 11.29 | 10.78 | 8.78 | 7.86 | 15.86 | 13.00 | 5.93 |
EV/FCF |
19.92 | 15.32 | 11.14 | 13.83 | 12.89 | 10.34 | 9.05 | 20.67 | 18.84 | 6.95 |
Quick Ratio |
0.51 | 0.50 | 0.48 | 0.51 | 0.51 | 0.56 | 0.53 | 0.50 | 0.48 | 0.47 |
Current Ratio |
0.90 | 0.88 | 0.88 | 0.91 | 0.94 | 0.98 | 0.95 | 0.93 | 0.91 | 0.90 |
Net Debt/EBITDA |
0.89 | 0.38 | 0.66 | 0.75 | 1.43 | 0.11 | 0.70 | 1.08 | 0.91 | 0.90 |
Debt/Assets |
10.00% | 6.54% | 7.65% | 10.08% | 11.66% | 9.30% | 11.47% | 12.38% | 10.74% | 13.27% |
Debt/Equity |
4.38 | 5.58 | 7.19 | 80.01 | 11.44 | (4.91) | 1.50 | 1.53 | 1.84 | 2.10 |
Asset Turnover |
4.47 | 4.53 | 4.40 | 4.19 | 4.21 | 4.55 | 4.67 | 4.60 | 4.44 | 4.77 |
Operating CF/Net income |
2.49 | 2.31 | 2.24 | 1.59 | 1.73 | (0.65) | 2.74 | 0.85 | 4.13 | 2.23 |
Capex/Depreciation |
(0.63) | (0.44) | (0.47) | (0.70) | (0.80) | (0.43) | (0.62) | (0.58) | (1.08) | (1.18) |
Interest Coverage |
9.02 | 13.86 | 10.22 | 11.23 | 13.52 | (37.24) | 7.05 | 8.26 | 7.30 | 10.91 |
| 122.67% | 207.72% | 473.26% | 518.18% | (1,206.73%) | (316.56%) | 28.31% | 64.85% | 17.38% | 104.01% | |
| 2.16% | 2.33% | 2.93% | 2.98% | 3.03% | (8.17%) | 2.23% | 4.54% | 1.06% | 4.64% | |
ROIC |
32.52% | 66.57% | 51.12% | 61.99% | 31.17% | 0.00% | 16.90% | 17.29% | 19.36% | 24.77% |
Return on Tangible Assets |
(51.08%) | (34.47%) | (44.78%) | (96.90%) | (391.77%) | (495.87%) | 266.24% | (2,000.59%) | (50.84%) | (159.04%) |
Average Days of Receivables |
28.65 | 29.64 | 29.22 | 28.49 | 31.37 | 27.55 | 25.19 | 24.59 | 24.56 | 22.81 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
2.02% | 1.93% | 2.03% | 2.03% | 1.81% | 5.00% | 1.67% | 1.57% | 2.02% | 1.49% |
Intangible Assets out of Total Assets |
0.23 | 0.20 | 0.22 | 0.23 | 0.25 | 0.19 | 0.23 | 0.26 | 0.25 | 0.27 |
Share Based Compensation of Revenue |
0.05% | 0.05% | 0.05% | 0.04% | 0.05% | 0.04% | 0.03% | 0.04% | 0.04% | 0.04% |
Graham Net Nets |
(0.37) | (0.42) | (0.53) | (0.60) | (0.73) | (0.61) | (0.47) | (0.43) | (0.49) | (0.50) |
Graham Number |
40.33 | 26.00 | 25.25 | 7.91 | 21.86 | 39.29 | 36.11 | 48.93 | 20.10 | 39.15 |
Earnings Yield |
2.57% | 3.37% | 4.81% | 6.01% | 6.26% | (17.26%) | 4.94% | 8.19% | 2.28% | 8.41% |
Free Cash Flow Yield |
5.29% | 6.71% | 9.52% | 7.82% | 9.06% | 9.44% | 11.76% | 5.36% | 5.70% | 15.83% |
Revenue per Share |
1,657.89 | 1,480.88 | 1,294.61 | 1,144.46 | 1,039.19 | 927.29 | 854.51 | 770.82 | 701.29 | 692.01 |
Operating CF per Share |
19.99 | 17.55 | 19.31 | 12.97 | 12.95 | 10.78 | 11.15 | 6.48 | 6.89 | 14.98 |
Capex per Share |
(3.45) | (2.45) | (2.26) | (2.38) | (2.13) | (1.63) | (1.47) | (1.51) | (2.14) | (2.19) |
Free Cash Flow per Share |
16.55 | 15.10 | 17.05 | 10.59 | 10.82 | 9.15 | 9.68 | 4.97 | 4.75 | 12.79 |
Cash per Share |
22.48 | 15.78 | 12.80 | 16.25 | 12.37 | 22.45 | 16.06 | 11.44 | 11.15 | 12.92 |
Shareholders Equity per Share |
9.01 | 3.96 | 3.29 | 0.34 | 2.84 | (4.10) | 14.24 | 14.00 | 9.45 | 10.03 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
9.01 | 3.96 | 3.29 | 0.34 | 2.84 | (4.10) | 14.24 | 14.00 | 9.45 | 10.03 |
Free Cash Flow |
3,207.14 | 2,997.51 | 3,452.98 | 2,206.77 | 2,228.37 | 1,873.73 | 2,035.10 | 1,083.08 | 1,037.74 | 2,713.88 |
Working Capital |
(5,581.47) | (6,559.24) | (6,032.38) | (3,888.19) | (2,556.03) | (797.38) | (1,449.24) | (1,975.32) | (2,514.86) | (2,428.52) |
Capital Expenditures |
(667.98) | (487.17) | (458.36) | (496.32) | (438.22) | (333.31) | (308.93) | (328.31) | (466.40) | (464.62) |
Net Current Asset Value |
(22,603.95) | (18,597.11) | (19,093.64) | (16,899.58) | (17,950.78) | (12,058.76) | (8,046.72) | (8,725.51) | (8,948.71) | (8,656.25) |
EV/EBIT |
24.30 | 21.12 | 16.43 | 12.90 | 12.21 | 0.00 | 16.57 | 15.51 | 18.44 | 12.36 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Operating Income |
23.04 | 20.54 | 15.49 | 11.92 | 10.45 | 0.00 | 15.56 | 14.00 | 17.16 | 11.23 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.42 | 0.51 | 0.46 | 0.33 | 0.25 | 0.52 | 0.28 | 0.30 | 0.24 | 0.26 |
Cash ROIC |
23.30% | 36.08% | 42.92% | 24.09% | 22.70% | 23.79% | 18.74% | 10.61% | 12.51% | 29.08% |
Accounts Receivable Turnover |
13.09 | 13.11 | 13.24 | 12.89 | 13.08 | 14.21 | 15.15 | 15.54 | 15.72 | 16.88 |
Accounts Payable Turnover |
5.87 | 5.87 | 5.89 | 5.89 | 5.94 | 6.15 | 6.32 | 6.25 | 6.02 | 6.36 |
Inventory Turnover |
15.69 | 15.58 | 15.34 | 14.89 | 14.81 | 15.62 | 15.18 | 13.97 | 13.40 | 13.92 |
Average Days of Payables |
64.46 | 65.46 | 66.07 | 63.70 | 67.01 | 62.65 | 59.39 | 59.97 | 62.40 | 61.25 |
Days of Inventory on Hand |
24.14 | 24.41 | 25.16 | 24.66 | 27.09 | 24.88 | 23.14 | 26.64 | 28.15 | 27.45 |
Average Receivables |
24,548.56 | 22,430.01 | 19,806.72 | 18,507.15 | 16,361.89 | 13,363.74 | 11,853.49 | 10,808.78 | 9,739.60 | 8,699.41 |
Average Payables |
52,830.96 | 48,389.10 | 43,014.47 | 39,101.42 | 34,857.50 | 30,045.06 | 27,610.97 | 26,120.46 | 24,665.18 | 22,406.38 |
Average Inventory |
19,745.66 | 18,226.80 | 16,505.58 | 15,462.37 | 13,978.82 | 11,824.77 | 11,489.38 | 11,689.97 | 11,092.68 | 10,239.51 |
Average Assets |
71,845.89 | 64,830.21 | 59,559.69 | 56,949.21 | 50,806.32 | 41,723.41 | 38,420.91 | 36,493.16 | 34,476.99 | 30,800.24 |
Average Common Equity |
1,266.91 | 726.51 | 368.78 | 327.84 | (127.61) | 1,076.78 | 3,021.58 | 2,557.21 | 2,096.93 | 1,372.89 |
Columns are period end dates